1. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications;Nauck;Am. J. Med.,2011
2. Overview of glucagon-like peptide-1 receptor agonists for the treatment of patients with type 2 diabetes;Tran;Am. Health Drug Benefits,2017
3. Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis;Wang,2017
4. Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor;Kimura;Diab. Vasc. Dis. Res.,2017
5. GLP-1 receptor signalling promotes beta-cell glucose metabolism via mTOR-dependent HIF-1alpha activation;Carlessi;Sci. Rep.,2017